Clinical Trial Update: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.

View source ↗

Summary

The clinical trial investigating how ceftriaxone and/or fluoroquinolone treatment affects gut microbiota in hospitalized patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Fluoroquinolone (fluoroquinolone)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bacterial Infections | Status: TERMINATED